Helix BioMedix, Inc. (HXBM)
Develops peptide treatments for rare skin diseases and aging skin.
$1.79+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-68.4%
The outlook
HXBM is trading near its 52-week low, sitting just 17% of the way up from its bottom, with price movement mixed against its moving averages. Analyst coverage appears limited. The overall sentiment leans bearish based on current market data.
What’s behind the score
Price trendMixed vs its moving averages
52-week range17% of the way from its 52-week low to high
Market cap
$402,227
52-wk high
$5.67
52-wk low
$1.00
50-day avg
$1.77
200-day avg
$2.12
Trailing P/E
—